US$ 22.35
glp 1 agonist effects GLP-1 and Anesthesia: Considerations and Cautions for CRNAs Glucagon-Like Peptide-1: New Regulator in
Description
As shown in Scheme 10
2021;46 doi: 10.1016/j.molmet.2020.101102
[3] The availability of an oral formulation offers an alternative for patients who prefer or require an oral medication over injections
doi: 10.1001/jamanetworkopen.2024.35247, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 162

Typically, GI side effects of GLP-1s, such as nausea and vomiting, are dose-dependent, mild-to-moderate in severity, and occur mostly during initiation of therapy and up-titration

To view a copy of this licence, visit About this article Cite this article Sawami, K., Tanaka, A
